Literature DB >> 19484773

Characterization of the biological effect of fish fibrin glue in experiments on rats: immunological and coagulation studies.

Ivo Laidmäe1, Tiit Salum, Evelyn S Sawyer, Paul A Janmey, Raivo Uibo.   

Abstract

Fibrin glues (FG) of human or bovine origin are widely used for haemostasis and wound healing. In addition FGs are studied in many biomedical areas like cell therapy or tissue engineering. As any mammalian plasma products FG-s pose risk of transmission of bacteria, viruses, or prions and may compromise patient homeostasis. In this study, we examined coagulation parameters and immunological status of rats treated with salmon-derived FG. We evaluated the changes in thrombin time, prothrombin activity, and presence of antibodies on 46 Wistar rats. This study shows that salmon-derived FG, injected intraperitoneally, does not cause coagulation disturbances in the peripheral blood. After a first challenge with salmon-derived FG there were low but detectable amounts of antibodies revealed by ELISA and immunoblot. After a second administration there was substantial elevation of antibodies to FG components and other copurifying plasma proteins. Antibody reactivity to human Factor Va, revealed in three animals, was not associated with FG application. Taken together, blood immunological and coagulation parameters support the suitability of salmon-derived FG in the development of fibrin sealants for medical use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19484773      PMCID: PMC3210033          DOI: 10.1002/jbm.a.32505

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  20 in total

1.  Fibrin-based biomaterials to deliver human growth factors.

Authors:  Catalina Wong; Elisabeth Inman; Reiner Spaethe; Sam Helgerson
Journal:  Thromb Haemost       Date:  2003-03       Impact factor: 5.249

2.  Transscleral diffusion of carboplatin: an in vitro and in vivo study.

Authors:  Amanda E Simpson; Jake A Gilbert; David E Rudnick; Dayle H Geroski; Thomas M Aaberg; Henry F Edelhauser
Journal:  Arch Ophthalmol       Date:  2002-08

Review 3.  Fibrin sealant: a review of its use in surgery and endoscopy.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

4.  Purification of salmon clotting factors and their use as tissue sealants.

Authors:  L Z Wang; J Gorlin; S E Michaud; P A Janmey; R P Goddeau; R Kuuse; R Uibo; D Adams; E S Sawyer
Journal:  Thromb Res       Date:  2000-12-15       Impact factor: 3.944

5.  The efficacy of controlled antibiotic release for prevention of polyethyleneterephthalate- (Dacron-) related infection in cardiovascular surgery.

Authors:  M Karck; L Forgione; A Haverich
Journal:  Clin Mater       Date:  1993

6.  Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants.

Authors:  Sarah E Michaud; Louise Z Wang; Neha Korde; Robert Bucki; Paramjeet K Randhawa; Jennifer J Pastore; Hervé Falet; Karin Hoffmeister; Reet Kuuse; Raivo Uibo; Julia Herod; Evelyn Sawyer; Paul A Janmey
Journal:  Thromb Res       Date:  2002-09-01       Impact factor: 3.944

7.  Distribution and serum concentration of sisomicin released from fibrin glue-sealed dacron graft in the rat and human.

Authors:  T Osada; K Yamamura; K Yano; K Fujimoto; K Mizuno; T Sakurai; T Nabeshima
Journal:  J Biomed Mater Res       Date:  2000-10

8.  Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.

Authors:  T L Ortel; M C Mercer; E H Thames; K D Moore; J H Lawson
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

Review 9.  Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.

Authors:  Michael B Streiff; Paul M Ness
Journal:  Transfusion       Date:  2002-01       Impact factor: 3.157

10.  [Fibrin matrix enhances adherence of peripheral nerve regenerative cells].

Authors:  D F Kalbermatten; P J Kingham; D Mahay; H Balcin; G Pierer; G Terenghi
Journal:  Handchir Mikrochir Plast Chir       Date:  2008-04       Impact factor: 1.018

View more
  4 in total

1.  The potential for salmon fibrin and thrombin to mitigate pain subsequent to cervical nerve root injury.

Authors:  Christine L Weisshaar; Jessamine P Winer; Benjamin B Guarino; Paul A Janmey; Beth A Winkelstein
Journal:  Biomaterials       Date:  2011-09-22       Impact factor: 12.479

2.  Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation.

Authors:  Kelli G Sharp; Amanda R Dickson; Steve A Marchenko; Kelly M Yee; Pauline N Emery; Ivo Laidmåe; Raivo Uibo; Evelyn S Sawyer; Oswald Steward; Lisa A Flanagan
Journal:  Exp Neurol       Date:  2012-03-05       Impact factor: 5.330

3.  The impact of tissue glue in wound healing of head and neck patients undergoing neck dissection.

Authors:  Che-Wei Huang; Chen-Chi Wang; Rong-San Jiang; Yu-Chia Huang; Hui-Ching Ho; Shih-An Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-09       Impact factor: 2.503

4.  Salmon fibrinogen and chitosan scaffold for tissue engineering: in vitro and in vivo evaluation.

Authors:  Ivo Laidmäe; Kaspars Ērglis; Andrejs Cēbers; Paul A Janmey; Raivo Uibo
Journal:  J Mater Sci Mater Med       Date:  2018-11-30       Impact factor: 3.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.